Guardian Pharmacy Services, Inc. (New York Stock Exchange:GRDN)
| Market Cap | 2.61B+73.0% |
| Revenue (ttm) | 1.46B+10.3% |
| Net Income | 65.91M+180.2% |
| EPS | 1.03+168.2% |
| Shares Out | 63.32M |
| PE Ratio | 39.06 |
| Forward PE | 28.68 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 99,606 |
| Open | 40.79 |
| Previous Close | 40.68 |
| Day's Range | 40.19 - 41.20 |
| 52-Week Range | 23.14 - 48.33 |
| Beta | 0.10 |
| Analysts | Buy |
| Price Target | 50.67(+23.16%) |
| Earnings Date | Nov 9, 2026 |
Insiders here have filed 17 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About GRDN
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$GRDN stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in GRDN holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by GRDN's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
GRDN Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New GRDN patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to GRDN from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in GRDN
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $38.14M |
| IWMiShares Russell 2000 ETF | $33.85M |
| FPXFirst Trust US Equity Opportunities ETF | $12.49M |
| IWOiShares Russell 2000 Growth ETF | $12.13M |
| VXFVanguard Extended Market ETF | $11.98M |
| FYCFirst Trust Small Cap Growth AlphaDEX Fund | $9.91M |
Estimated from each fund’s disclosed top holdings × AUM
GRDN Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from GRDN’s recent data — informational, not investment advice